BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 22516063)

  • 1. Attenuation of early atherogenesis in low-density lipoprotein receptor-deficient mice by proteasome inhibition.
    Wilck N; Fechner M; Dreger H; Hewing B; Arias A; Meiners S; Baumann G; Stangl V; Stangl K; Ludwig A
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1418-26. PubMed ID: 22516063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
    Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.
    Stachon P; Peikert A; Michel NA; Hergeth S; Marchini T; Wolf D; Dufner B; Hoppe N; Ayata CK; Grimm M; Cicko S; Schulte L; Reinöhl J; von zur Muhlen C; Bode C; Idzko M; Zirlik A
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2237-45. PubMed ID: 25104800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice.
    Potì F; Gualtieri F; Sacchi S; Weißen-Plenz G; Varga G; Brodde M; Weber C; Simoni M; Nofer JR
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1505-12. PubMed ID: 23640484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice.
    Rinne P; Silvola JM; Hellberg S; Ståhle M; Liljenbäck H; Salomäki H; Koskinen E; Nuutinen S; Saukko P; Knuuti J; Saraste A; Roivainen A; Savontaus E
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1346-54. PubMed ID: 24790139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with cilostazol and pravastatin improves antiatherogenic effects in low-density lipoprotein receptor knockout mice.
    Park KY; Heo TH
    Cardiovasc Ther; 2018 Dec; 36(6):e12476. PubMed ID: 30378752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
    Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oats (Avena sativa) reduce atherogenesis in LDL-receptor-deficient mice.
    Andersson KE; Svedberg KA; Lindholm MW; Oste R; Hellstrand P
    Atherosclerosis; 2010 Sep; 212(1):93-9. PubMed ID: 20553794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological inhibition of the chemokine receptor, CX3CR1, reduces atherosclerosis in mice.
    Poupel L; Boissonnas A; Hermand P; Dorgham K; Guyon E; Auvynet C; Charles FS; Lesnik P; Deterre P; Combadiere C
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2297-305. PubMed ID: 23887641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice.
    Mulvihill EE; Assini JM; Sutherland BG; DiMattia AS; Khami M; Koppes JB; Sawyez CG; Whitman SC; Huff MW
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):742-8. PubMed ID: 20110573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogen decreases athero-susceptibility in apolipoprotein B-containing lipoproteins and aorta of apolipoprotein E knockout mice.
    Song G; Tian H; Qin S; Sun X; Yao S; Zong C; Luo Y; Liu J; Yu Y; Sang H; Wang X
    Atherosclerosis; 2012 Mar; 221(1):55-65. PubMed ID: 22209213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions.
    Yoshii T; Iwai M; Li Z; Chen R; Ide A; Fukunaga S; Oshita A; Mogi M; Higaki J; Horiuchi M
    Hypertens Res; 2006 Jun; 29(6):457-66. PubMed ID: 16940709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P55 tumour necrosis factor receptor in bone marrow-derived cells promotes atherosclerosis development in low-density lipoprotein receptor knock-out mice.
    Xanthoulea S; Gijbels MJ; van der Made I; Mujcic H; Thelen M; Vergouwe MN; Ambagts MH; Hofker MH; de Winther MP
    Cardiovasc Res; 2008 Nov; 80(2):309-18. PubMed ID: 18628255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corosolic acid ameliorates atherosclerosis in apolipoprotein E-deficient mice by regulating the nuclear factor-κB signaling pathway and inhibiting monocyte chemoattractant protein-1 expression.
    Chen H; Yang J; Zhang Q; Chen LH; Wang Q
    Circ J; 2012; 76(4):995-1003. PubMed ID: 22293444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega-3 fatty acids ameliorate atherosclerosis by favorably altering monocyte subsets and limiting monocyte recruitment to aortic lesions.
    Brown AL; Zhu X; Rong S; Shewale S; Seo J; Boudyguina E; Gebre AK; Alexander-Miller MA; Parks JS
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2122-30. PubMed ID: 22814747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE
    Xiong W; Wang X; Dai D; Zhang B; Lu L; Tao R
    Thromb Haemost; 2017 Jan; 117(2):401-414. PubMed ID: 27831589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice.
    Liu TT; Zeng Y; Tang K; Chen X; Zhang W; Xu XL
    Atherosclerosis; 2017 Jul; 262():39-50. PubMed ID: 28500865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor δ agonist GW1516 attenuates diet-induced aortic inflammation, insulin resistance, and atherosclerosis in low-density lipoprotein receptor knockout mice.
    Bojic LA; Burke AC; Chhoker SS; Telford DE; Sutherland BG; Edwards JY; Sawyez CG; Tirona RG; Yin H; Pickering JG; Huff MW
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):52-60. PubMed ID: 24158519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-atherogenic effect of BHB-TZD having inhibitory activities on cyclooxygenase and 5-lipoxygenase in hyperlipidemic mice.
    Choi JH; Jeon HJ; Park JG; Sonn SK; Lee MR; Lee MN; You HJ; Kim GY; Kim JH; Lee MH; Kwon OS; Nam KH; Kim HC; Jeong TS; Lee WS; Oh GT
    Atherosclerosis; 2010 Sep; 212(1):146-52. PubMed ID: 20684827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct effect of an acyl-CoA:cholesterol acyltransferase inhibitor, F-1394, on atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
    Chiwata T; Aragane K; Fujinami K; Kojima K; Ishibashi S; Yamada N; Kusunoki J
    Br J Pharmacol; 2001 Aug; 133(7):1005-12. PubMed ID: 11487509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.